Skip to main content

Animations

MJFF Publications

8361 - 8370 of 8816 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2018
  • Summary Details
    OPEN
    Title: Exercise Reverses Dysregulation of T-Cell-Related Function in Blood Leukocytes of Patients With Parkinson's Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2019.01389
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-019-14279-8
    Citation Count: 397
  • Summary Details
    OPEN
    Title: Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2020/9716317
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson’s disease
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-020-0401-2
    Citation Count: 98
  • Summary Details
    OPEN
    Title: The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-019-1394-3
    Citation Count: 112
  • Summary Details
    OPEN
    Title: miR-34a as hub of T cell regulation networks
    Journal Name: Journal for ImmunoTherapy of Cancer
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40425-019-0670-5
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Parkinson's Disease Detection Using Isosurfaces-Based Features and Convolutional Neural Networks
    Journal Name: Frontiers in Neuroinformatics
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fninf.2019.00048
    Citation Count: 86
  • Summary Details
    OPEN
    Title: Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer’s Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-019-45896-4
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2019.05.064
    Citation Count: 309
  • Summary Details
    OPEN
    Title: Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-018-0223-3
    Citation Count: 135
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.